Memphis Pharmaceutical
MPCI
1.10%
100.92
1.10
MPCI
Cairo-Mubasher: Memphis Pharmaceutical posted EGP 15.4 million ($2 million) in losses for the 10-month period ended in April 2015, rising 1,238% compared with EGP 1.2 million ($156,000) a year earlier.
The company had posted losses of EGP 11.65 million ($1.5 million) for the nine-month period ended in December 2014, versus earnings of EGP 1 million ($130,600) in the same period a year ago.
Memphis operates with EGP 56.2 million in capital, divided into 5.6 million shares at a par value of EGP 10 each.
Source:
Mubasher